On Monday, Addus HomeCare earned a positive adjustment to its Relative Strength (RS) Rating, from 68 to 73.
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the market's biggest winners tend to have an RS Rating north of 80 as they launch their largest runs. See if Addus HomeCare can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Addus HomeCare is working on a flat base with a 136.12 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal.
The company reported 13% EPS growth in its most recent report, while sales growth came in at 7%.
Addus HomeCare holds the No. 5 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
